Claim Missing Document
Check
Articles

Found 2 Documents
Search

Bioactive Compounds from Penicillium sp. Inhibit Antiapoptotic Bcl-2, Bcl-XL and Mcl-1: An in silico Study Massardi, Adhie; Bahry, Sandy Samsul; Rahmawati, Nur Anindya; Shabirah, Carissa Azmi; Pangastuti, Artini
Molecular and Cellular Biomedical Sciences Vol 7, No 2 (2023)
Publisher : Cell and BioPharmaceutical Institute

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.21705/mcbs.v7i2.330

Abstract

Background: Antiapoptotic Bcl-2 proteins are overexpressed in cancer cells, leading to inhibition of apoptosis and the development of therapeutic resistance. Targeting only one type of antiapoptotic protein may have limited efficacy in cancer therapy. Anticancer drugs capable of inhibiting Bcl-2, Bcl-XL and Mcl-1 simultaneously are necessary to be explored. Penicillium sp. produces various bioactive compounds with anticancer, antibacterial, and antiviral activities. The aim of this research was to determine the best bioactive compound candidates for inhibiting Bcl-2, Bcl-XL, and Mcl-1 proteins.Materials and methods: Molecular docking analysis was conducted to estimate the binding affinity of Penicillium sp. bioactive compounds with Bcl-2, Bcl-XL, and Mcl-1 proteins. Compounds with the lowest binding energies were visualized using PyMol and Ligplot+ and further subjected to drug-likeness testing based on Lipinski's rule of five.Results: Bioactive compounds with the highest binding affinities were verruculogen and wortmannin. Wortmannin complied with Lipinski's rule of five. Meanwhile, verruculogen violated one out of the five rules by having a molecular weight >500 Da. Both compounds could be used as oral drugs.Conclusion: Verruculogen and wortmannin from Penicillium sp. show significant potential as oral anticancer drug candidates.Keywords: Bcl-2, Bcl-XL, Mcl-1, Penicillium sp., in silico
Development and Testing of a Portable Air Purifier with Chemical and UV-C Filtration for Virus and Pollutant Removal Yunita, Ailsa Rahma; Vegasty, Sabella; Izati, Zhahira Nur; Massardi, Adhie; Kusumaningsih, Triana; Firdaus, Maulidan
Jurnal Riset Kimia Vol. 16 No. 2 (2025): September
Publisher : Universitas Andalas

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.25077/jrk.v16i2.790

Abstract

COVID-19 has profoundly impacted global health due to its severe respiratory effects. Similarly, respiratory issues are also triggered by pollutants such as O3, SO2, NO2, and CO. In response to these challenges, this study developed a portable air purifier called APMIKAV, incorporating sodium lauryl sulfate, activated carbon, and UV-C light as filter components. APMIKAV fabrication aimed to build a portable air purifier and study its effectiveness in filtering air containing viruses and pollutants into clean air. The APMIKAV utilized a three-stage filtration process that included a surfactant filter for pollutant removal and virus lysis, an activated carbon filter for pollutant adsorption, and a UV-C filter to deactivate viral DNA and RNA. Methods included designing, assembling, and testing. Antiviral testing was carried out with GeNose C19 on patients who tested positive for COVID-19, while air parameters were analyzed using an NDIR analyzer for CO and an air sampling impinger for O3, SO2, and NO2. Test with GeNose C19 showed negative results. Pollutant concentrations post-filtration average efficiency were 98.17%, 68.84%, 49.29%, and 66.34%, for NO2, O3, SO2, and CO, respectively. Overall, the multi-stage filtration process provided a robust solution for enhancing air quality in environments susceptible to both pollution and viral transmission, which confirmed APMIKAV's effectiveness in providing cleaner and safer air.